Skip to content
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
KeyPediaKeyPedia
  • Company
  • Platform
  • Media
  • KeyPedia Lite
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Baxter Pharmaceutical Solutions, LLC
FDA Inspection•Baxter Pharmaceutical Solutions, LLC•December 11, 2025

Baxter Pharmaceutical Solutions, LLC – FDA Inspection, Dec 11, 2025

Record Details

This FDA Inspection record concerns Baxter Pharmaceutical Solutions, LLC, with an inspection on December 11, 2025, issued by the Detroit District Office, covering biologics.

Company
Baxter Pharmaceutical Solutions, LLC
Inspection Date
December 11, 2025
Product Type
Biologics
Office
Detroit District Office
People
  • Lizaida Perez (FDA Personnel)
  • Priscilla M. Pastrana (Company Rep)

ID · e3888c4a-f3ae-412d-ba8b-7ba36c4e3491

Inspection Facts

Inspection number
1290838
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

FDA Citations

2
  1. 21 CFR 211.192Quality control unit review of records
  2. 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Baxter Pharmaceutical Solutions, LLC

19
DateClassificationOfficeProject area
September 24, 2024Not classifiedDetroit District Office
July 26, 2024Not classifiedDetroit District Office
February 20, 2024Not classifiedDetroit District Office
February 17, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 10, 2021VAICenter for Biologics Evaluation and ResearchVaccines and Allergenic Products
View all 19 other inspections on the company page

Other documents for Baxter Pharmaceutical Solutions, LLC

5
Document
FDA Inspection 1242468 · September 24, 2024 
FDA Inspection 1243512 · July 26, 2024 
FDA Inspection 1230675 · February 20, 2024 
FDA Inspection 1200813 · February 17, 2023 
FDA Inspection 1157719 · November 10, 2021 
View Company ProfileHave an account? Sign in to open in Dashboard

Or discuss it with

What you get

  1. A document

    One file.

    • One FDA document, such as a Form 483
    • Yours for life in your Library
    • Each has its own price
    here
  2. The profile

    All the documents, plus intelligence about the company.

    • Every Baxter Pharmaceutical Solutions, LLC document on file
    • The KRA score, which a single document does not include
    • Observations and inspection history
  3. Access

    This, for every company on KeyPedia.

    • Combine profiles in one search
    • Search across any modality: products, industry types, drugs, devices and recalls
    • Track everything as it changes
    • Other agencies too, such as EMA, Health Canada and UK MHRA
    Browse free in KeyPedia Lite
KeyPedia
The intelligence layer for life sciences
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
Quick Links
HomePlatformUse CasesHardwarePricingResearchOur TechnologyFAQMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPrograms & Partnerships
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.